about
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists o...
Read More
2.58
0.01
(0.39%)
225.2K
XNYS Volume
XNYS 10 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Annovis Bio Inc is on 20 Mar 2026 for the purpose of Annovis Bio Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Annovis Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..